New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Depression in Cancer Patients

Patients with cancer and depression frequently do not receive effective treatment.

Diabetes Risk for Lymphoma Survivors

Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors.

Colonic Diverticular Disease, Cancer

Colonic diverticular disease does not appear to be linked to an increased risk of subsequent colorectal cancer.

Botulinum Toxin as Cancer Treatment?

The therapeutic effects of systemic chemotherapy were enhanced by vagotomy or botulinum toxin type A treatment in a study.

Active Surveillance for Testicular Cancer

Active surveillance for clinical stage I (CSI) testis cancer leads to excellent outcomes.

NSAIDs, Breast Cancer Recurrence

Daily use of NSAIDs may reduce the recurrence rate of hormone-responsive breast cancer in overweight or obese women.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

Family Conflict Can Derail Cancer Surgery Recovery

Family Conflict Can Derail Cancer Surgery Recovery

Cancer patients burdened by stress and family conflicts before surgery may face a higher risk for complications following their operation.

Breast Cancer Subtype Affects Survival with Spinal Metastasis

Breast Cancer Subtype Affects Survival with Spinal Metastasis

For patients with breast cancer with spinal metastases, estrogen receptor (ER)/hormone receptor (HR)-negative status is associated with worse survival.

Lymphoseek Gains Orphan Drug Designation for Head, Neck Cancer Detection

Lymphoseek Gains Orphan Drug Designation for Head, Neck Cancer Detection

Navidea announced that the Food and Drug Administration (FDA) has granted Lymphoseek (technetium Tc 99m tilmanocept) injection an Orphan Drug Designation for use in sentinel lymph node detection in patients with head and neck cancer.

Head, Neck Cancer Cancer Drug May Overcome Cetuximab Resistance

Head, Neck Cancer Cancer Drug May Overcome Cetuximab Resistance

The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer.

PET-CT Prognostic After Induction Tx in Follicular Lymphoma

PET-CT Prognostic After Induction Tx in Follicular Lymphoma

The five-point Deauville scale (5PS), used to score 18F-fluorodeoxyglucose (FDG) uptake on FDG positron emission tomography-computed tomography (PET-CT) scans, has prognostic value in follicular lymphoma.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Clinical review - Brain tumoursExternal web site

Clinical review – Brain tumours

2.50 Credits

Changing moles - Red flag symptomsExternal web site

Changing moles - Red flag symptoms

0.50 Credits

Sign Up for Free e-newsletters